A number of late-phase clinical trials in prostate cancer have opened in recent months. Maybe one of your patients could
Continue reading »Home »
Old Saying About Prostate Cancer Not True When It’s Metastatic
Nearly 80% of men with metastatic prostate cancer died from their malignancy, according to a retrospective cohort study involving 26,000-plus
Continue reading »Swedish Prostate Cancer Screening Method Cuts MRIs, Biopsies
In a randomized trial of prostate cancer screening methods, a blood-based diagnostic test and MRI with subsequent targeted plus systematic
Continue reading »Biomarkers Pinpoint Resistant Prostate Cancer That May Benefit From Addition of Apalutamide
NEW YORK (Reuters Health) – Biomarkers can be used to identify patients with prostate cancer refractory to first-line androgen deprivation
Continue reading »Loss of MAP3K7, CHD1 Expression Spur Recurrence in Prostate Cancer
NEW YORK (Reuters Health) – Loss of MAP3K7 protein expression, seen in approximately 40% of prostate cancer patients, is a
Continue reading »Comtan
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. COMTAN® entacapone Consumer Medicine Information What is
Continue reading »Marvelon
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MARVELON® 28 (mar-ve-lon) Ethinylestradiol and Desogestrel Consumer
Continue reading »Artificial nose identifies malignant tissue in brain tumours during surgery
An artificial nose developed at Tampere University, Finland, helps neurosurgeons to identify cancerous tissue during surgery and enables more precise
Continue reading »New data confirm antioxidants accelerate spread of malignant melanoma
Now there is additional evidence of the connection between the intake of antioxidant supplements and increased tumor growth. Experiments on
Continue reading »